{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Project Podcast","title":"Paraquat, Parkinson’s Disease, and EPA Oversight | Carey Gillam","html":"","width":"100%","height":180,"duration":2198,"description":"What happens when the agency responsible for protecting public health relies on safety information from the companies it's supposed to regulate?\nIn this episode of The Healthy Project Podcast, host Corey Dion Lewis sits down with award-winning investigative journalist Carey Gillam, editor-in-chief of The New Lede, to examine the relationship between pesticide regulation, corporate accountability, and public health.\nDrawing on her investigation co-published with The Guardian, Gillam discusses internal Syngenta documents on paraquat, a widely used herbicide linked in scientific research to Parkinson's disease. The documents raise questions about what the company knew, what information was shared with the Environmental Protection Agency (EPA), and whether farmers and agricultural workers received adequate warnings about potential health risks.\nThe conversation goes beyond one chemical or one company. Corey and Carey explore how pesticide safety decisions are made, how corporate research influences regulatory oversight, and why environmental health concerns affect communities far beyond agricultural fields.\nIn this episode, you'll learn:\nWhat internal Syngenta documents reveal about the company's knowledge of paraquat and potential neurological risks.\nWhat researchers have found about the relationship between paraquat exposure and Parkinson's disease, and why the findings remain contested.\nHow the EPA evaluates pesticide safety and why its reliance on industry-provided research raises concerns.\nHow corporate influence can affect independent scientific research, public information, and regulatory decisions.\nWhy pesticide exposure, agricultural runoff, and water quality matter for communities, including those in Iowa.\nHow environmental health risks intersect with health equity, prevention, and corporate accountability.\nWhy Carey continues investigating these issues despite facing professional intimidation and personal challenges.\nCarey also shares the human stories...","thumbnail_url":"https://img.transistorcdn.com/MSRYwgzVwmOkZXeinjXJXt6vM1REXDF2oD3ZSMgwLMU/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lY2Zl/MzVlNDRkOWQ4MDEz/ZTNkOTY2MzMyNzYx/M2I0MC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}